ISCP Events
Starts: December 1, 2026
|Ends: December 1, 2026
Organizer: International Society of Cardiovascular Pharmacotherapy (ISCP) in collaboration with the Anticoagulation Forum
Website: https://us06web.zoom.us/webinar/register/5317951267291/WN_R01xn8mcTXahJajjHw9J7g

Live Webinar
Tuesday, 1 December 2026 | 23:00 GMT
• Americas: Tue 1 Dec – afternoon (18:00 New York)
• Europe/Africa: Tue 1 Dec – late evening (00:00 Wed 2 Dec in Madrid)
• Asia & Oceania: Wed 2 Dec – morning (07:00 Hong Kong, 12:00 New Zealand)
Direct oral anticoagulants (DOACs) are widely prescribed for the prevention and treatment of thromboembolism, but individual agents do not perform equally across all patient sub-populations. Applying standard prescribing protocols without considering physiological extremes or sex-specific risks can compromise anticoagulant efficacy or expose patients to avoidable bleeding.
This 1-hour, case-based webinar, organised by the International Society of Cardiovascular Pharmacotherapy (ISCP) in collaboration with the Anticoagulation Forum (AC Forum), addresses two groups that remain underrepresented in clinical trials: patients at extremes of body weight and women receiving DOAC therapy. Through two real-life clinical cases, the faculty will translate current evidence into practical prescribing and stewardship decisions.
Key Learning Objectives
After participating in this webinar, learners will be able to:
• Identify which DOAC agents and dosing strategies are appropriate for patients weighing over 100 kg, based on current evidence.
• Determine safe principles and dose adjustments when prescribing DOACs to underweight patients.
• Implement antithrombotic stewardship strategies to manage bleeding risk and heavy menstrual bleeding in women receiving DOACs.
• Apply evidence-based anticoagulation decision-making to real-life cases involving body weight extremes and women's health.
Target Audience
Physicians, clinical pharmacists and nurse practitioners who prescribe or manage DOACs, in cardiology, primary care, general medicine and hospital pharmacy.
Faculty
Moderator: Anthea Gregan, BPharm, PGDip(ClinPharm), MClinPharm, FANZCAP (Cardiol.) – ISCP Governor for New Zealand; Senior Clinical Pharmacist (Cardiology), Palmerston North Hospital
Antithrombotic Stewardship in Women's Health: Dr Tara Lech, PharmD – Director of Antithrombotic Services & Stewardship, Beth Israel Lahey Health; Board of Directors, Anticoagulation Forum
DOACs in Extremes of Body Weight: Dr Franco WT Cheng, PhD, BCCP, BCPS – ISCP Governor for Hong Kong; Clinical Pharmacist Practitioner, Gleneagles Hong Kong Hospital; Lecturer, The University of Hong Kong
Registration is free.
Stay updated
Sign up to receive news and updates on our iniciatives, content and events.